跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SEEBRI BREEZHALER INHALATION POWDER HARD CAPSULES 50MCG - PPB Drug Approval Details
Approvals
/
PPB
/
SEEBRI BREEZHALER INHALATION POWDER HARD CAPSULES 50MCG
Approved
STANDARD
SEEBRI BREEZHALER INHALATION POWDER HARD CAPSULES 50MCG
NOVARTIS PHARMACEUTICALS (HK) LIMITED
🇰🇪 Pharmacy and Poisons Board
Approval Date
Jun 21, 2024
Approval ID
5fd1c58f75f5a8cd
Company
NOVARTIS PHARMACEUTICALS (HK) LIMITED
Type
Standard
Approval Details
Approval Id
5fd1c58f75f5a8cd
Product Name
SEEBRI BREEZHALER INHALATION POWDER HARD CAPSULES 50MCG
Drug Hk Name
SEEBRI BREEZHALER INHALATION POWDER HARD CAPSULES 50MCG
Registration Code
HK-62328
Company Name
NOVARTIS PHARMACEUTICALS (HK) LIMITED
Company Detail Path
/organization/novartis-pharmaceuticals-hk-limited
Registration Category
Part 1, Schedule 1 & Schedule 3 Poison
Sale Requirement
Prescription only Medicines
Registration Date
2013-11-28
Company Address
SUITES 2303-2308, 23/F, NO.1111, KING'S ROAD, TAI KOO SHING, HONG KONG
Active Ingredients
Approved
Quick Info
Agency
PPB
Country
🇰🇪
Approval Date
Jun 21, 2024
Approval ID
5fd1c58f75f5a8cd
Type
Standard
Back to PPB Approvals